ZFIN ID: ZDB-FISH-150901-17744
Fish name: hkz04tTg; nz50Tg
Genotype: hkz04tTg; nz50Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by hkz04tTg; nz50Tg
No data available
GENE EXPRESSION
Gene expression in hkz04tTg; nz50Tg
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab1-bhmt physical alteration: anatomical structure Fig. 8 with image from Zhu et al., 2014
PHENOTYPE
Phenotype in hkz04tTg; nz50Tg
Phenotype Conditions Figures
cardiac muscle tissue regeneration decreased rate, abnormal cryoablation: cardiac ventricle, chemical treatment by injection: ilomastat Fig. 6 with image from Xu et al., 2018
cardiac muscle tissue regeneration decreased rate, abnormal cryoablation: cardiac ventricle, chemical treatment by injection: matrix metalloproteinase inhibitor Fig. 5 with image from Xu et al., 2018
cardiac ventricle macrophage increased amount, abnormal cryoablation: cardiac ventricle Fig. 4 with imageFig. 5 with imageFig. 6 with image from Xu et al., 2018
cardiac ventricle macrophage increased amount, ameliorated cryoablation: cardiac ventricle, chemical treatment by injection: matrix metalloproteinase inhibitor Fig. 5 with image from Xu et al., 2018
cardiac ventricle macrophage increased amount, ameliorated cryoablation: cardiac ventricle, chemical treatment by injection: ilomastat Fig. 4 with imageFig. 6 with image from Xu et al., 2018
cardiac ventricle neutrophil increased amount, abnormal cryoablation: cardiac ventricle Fig. 4 with imageFig. 5 with imageFig. 6 with image from Xu et al., 2018
cardiac ventricle neutrophil increased amount, ameliorated cryoablation: cardiac ventricle, chemical treatment by injection: ilomastat Fig. 4 with imageFig. 6 with image from Xu et al., 2018
cardiac ventricle neutrophil increased amount, ameliorated cryoablation: cardiac ventricle, chemical treatment by injection: matrix metalloproteinase inhibitor Fig. 5 with image from Xu et al., 2018
caudal fin vasculature anatomical region has extra parts of type neutrophil, abnormal chemical treatment by diet: cholesterol Fig. 2 from Yan et al., 2018
caudal fin vasculature anatomical region has extra parts of type macrophage, abnormal chemical treatment by diet: cholesterol Fig. 2 from Yan et al., 2018
caudal fin vasculature anatomical region has normal numbers of parts of type neutrophil, ameliorated chemical treatment by diet: cholesterol, chemical treatment by environment: ezetimibe Fig. 2 from Yan et al., 2018
caudal fin vasculature anatomical region has normal numbers of parts of type macrophage, ameliorated chemical treatment by diet: cholesterol, chemical treatment by environment: ezetimibe Fig. 2 from Yan et al., 2018
neutrophil decreased velocity, abnormal chemical treatment: dibenziodolium chloride Fig. 4 from Yan et al., 2014
neutrophil decreased velocity, abnormal amputation: caudal fin, chemical treatment: dibenziodolium chloride Fig. 4 from Yan et al., 2014
neutrophil chemotaxis decreased process quality, abnormal chemical treatment: dibenziodolium chloride Fig. 4 from Yan et al., 2014
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: dibenziodolium chloride Fig. 4 from Yan et al., 2014
neutrophil extravasation increased occurrence, abnormal chemical treatment by environment: lipopolysaccharide Fig. 4 from Philip et al., 2017

CITATIONS  (14)